Feiyang

Feiyang Ma is the Chief Technology Officer at ImmunoVec, where they are involved in developing life-saving gene therapy treatments. They have extensive experience as a bioinformatician, having worked on bioinformatics method development and data analysis across various institutions, including UCLA, Northwestern University, and the University of Michigan. Feiyang holds a PhD in Molecular Biology (Bioinformatics) from UCLA and a Bachelor's degree in Biological Science from Nankai University. Their collaborative efforts with more than 30 labs have resulted in over 50 high-impact publications with 1600+ citations.